Co-founder and Chief Executive Officer of Scandinavian Biopharma. Björn is former Chief Executive Officer of UniTech Pharma AB (2010-2011), Chief Business Officer of Crucell (2006-2009), a Dutch former listed company with facilities in the Netherlands, Switzerland and USA specializing in vaccines and biopharmaceutical technologies; Chief Executive Officer of Berna Biotech AG (2006-2009), a Swiss company specializing in the development and distribution of viral and bacterial vaccines; Chief Executive Officer of SBL Vaccin AB (2001-2006), a Swedish vaccine company that successfully developed and launched Dukoral®, a travel vaccine. Moreover, throughout the duration of his professional career, he had a seat on several company boards. Björn has also also been an Advisor to the Bill & Melinda Gates Foundation. Other assignment: Chairman of the board Sprint Bioscience.